A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the way for the world’s first commercialization of Nobel Prize-winning stem cell research. https://www.japantimes.co.jp/news/2026/02/20/japan/science-health/ips-cell-based-products/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #ips #parkinson039s #heartdisease #cuorips #sumitomopharma #health